qSARS-CoV-2 IgG/IgM Rapid Test - India CDSCO Medical Device Registration
qSARS-CoV-2 IgG/IgM Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000304_042c7727aefb19ff73b26f73740faa14_f6ed894c3bcb8d87160ef8d745f94add. This device is marketed under the brand name Cellex. The license holder is Concept Healthcare, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
Cellex
License Holder
Concept HealthcareDevice Class
Approving Authority
CDSCO
Product Information
The qSARS-CoV-2 IgG/IgM Rapid Test is intended for rapid and qualitative detection of antibodies indicative of SARS-CoV-2 infection and used as an aid for diagnosis of SARS-CoV-2 infection.
